All Type of News
90 companies apply for smart project
A total of 90 Korean firms applied for the government’s new growth engine smart project aiming to promote the nation’s biotechnology sector, according to the Ministry of Knowledge Economy.
They are seeking to condu...
Cho-A gear up for sports marketing
Cho-A Pharm, Korea’s small-sized drugmaker, has been putting more and more efforts into sports marketing in a bold step to raise sales on the domestic OTC market.
Sports marketing refers to the specific application...
Mundi Pharma files patent case against Hana Pharm in Korea
Switzerland based Mundi Pharma Laboratories has filed a lawsuit in the Seoul Central District Court on June 30, challenging Hana Pharm's recent launching for marketing the generic versions of Oxycontin (oxycodone HCl)...
Hanmi looking to boost Xenical generic sales
Hanmi Pharm aims to achieve the sales target of Lipidown (orlistat 120 mg) to 10 billion won this year, the company said on July 3.
The company held its Lipidown-promotion campaign where 900 salespersons and TV act...
Move to allocate new pharmacy school quota provokes protest
The government's move to allocate another 390 students to the quota for newly established pharmacy schools nationwide has provoked criticism from the heads of local universities and pharmacists.
The heads of pharma...
Imported in vitro diagnostics to be waived from reporting
Raw materials that will not be directly imported by drug manufacturers, including in vitro diagnostics, will be excluded from mandatory reporting to the Korea Food and Drug Administration from next year.
KFDA offic...
SK Chemicals to release new gout medication
SK Chemicals announced on July 2 that it received the marketing approval of Febuxostat 80 mg (brand name: Feburic), an inhibitor of xanthine oxidase that is indicated for use in the treatment of hyperuricemia and gout...
Combined hypertensive medicines market warming up
The domestic market of combined antihypertensive agents is gaining momentum with Korean leading manufacturers who see opportunities in the field.
Novartis Korea has pioneered the field with its Exforge in 2007 and ...
Daewoong, Neomics to develop anticancer drug
Daewoong Pharm has recently signed a memorandum of understanding with Neomics Co., a local biopharmaceutical company, to develop, manufacture and commercialize a novel antitumor drug using AIMP2-DX2, a tumor gene that...
Pharmaceutical output of Dong-A grows 16.6% in 2008
Dong-A Pharm posted 749.5 billion won in pharmaceutical production last year, a 16.6 percent gain from a year earlier.
Hanmi Pharm came in second with 579.6 billion won in drug output. The third player was Daewoong...
